Billable / Specific Code
ICD-10-CM C7A.029 is the diagnosis code for Malignant carcinoid tumor of the large intestine, unspecified portion. This code falls under the section "Malignant neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where C7A.029 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C7A.029 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C7A.029 is the ICD-10-CM diagnosis code for "Malignant carcinoid tumor of the large intestine, unspecified portion". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C7A.029 is C7A.02 ("Malignant carcinoid tumors of the appendix, large intestine, and rectum"). C7A.029 provides a more specific classification within this category.
C7A.029 is located in Section C7A — "Malignant neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
Use C7A.029 when the patients documented diagnosis matches "Malignant carcinoid tumor of the large intestine, unspecified portion" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant carcinoid tumor of the large intestine, unspecified portion is C7A.029.
Yes, C7A.029 can be used as a primary diagnosis code since it is billable and specific.
C7A.029 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C7A.029 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.